Select Publications

Journal articles

Menon P; Kiernan MC; Vucic S, 2014, 'Biomarkers and future targets for development in amyotrophic lateral sclerosis', Current Medicinal Chemistry, 21, pp. 3535 - 3550, http://dx.doi.org/10.2174/0929867321666140601161148

Kiernan MC; Maxwell I, 2014, 'Corrigendum to "Proceedings of the 15th Biennial Clinical Neurophysiology Workshop of the Australian and New Zealand Association of Neurologists, Sheraton Mirage Resort, Gold Coast, Queensland, Australia, 29th September-2nd October, 2013" [Clin. Neurophysiol. 125 (2014) e1-e7]', Clinical Neurophysiology, 125, pp. 2454, http://dx.doi.org/10.1016/j.clinph.2014.09.005

Simon NG; Vucic S; Joffe R; Kiernan MC, 2014, 'Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase', Journal of Neurology, 261, pp. 238 - 239, http://dx.doi.org/10.1007/s00415-013-7197-3

Menon P; Kiernan MC; Vucic S, 2014, 'Cortical excitability differences in hand muscles follow a split-hand pattern in healthy controls', Muscle and Nerve, 49, pp. 836 - 844, http://dx.doi.org/10.1002/mus.24072

Bae JS; Menon P; Mioshi E; Kiernan MC; Vucic S, 2014, 'Cortical hyperexcitability and the split-hand plus phenomenon: Pathophysiological insights in ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15, pp. 250 - 256, http://dx.doi.org/10.3109/21678421.2013.872150

Sung JY; Tani J; Park SB; Kiernan MC; Lin CSY, 2014, 'Early identification of 'acute-onset' chronic inflammatory demyelinating polyneuropathy', Brain, 137, pp. 2155 - 2163, http://dx.doi.org/10.1093/brain/awu158

Savage SA; Lillo P; Kumfor F; Kiernan MC; Piguet O; Hodges JR, 2014, 'Emotion processing deficits distinguish pure amyotrophic lateral sclerosis from frontotemporal dementia', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15, pp. 39 - 46, http://dx.doi.org/10.3109/21678421.2013.809763

Arnold R; Pussell BA; Howells J; Grinius V; Kiernan MC; Lin CSY; Krishnan AV, 2014, 'Evidence for a causal relationship between hyperkalaemia and axonal dysfunction in end-stage kidney disease', Clinical Neurophysiology, 125, pp. 179 - 185, http://dx.doi.org/10.1016/j.clinph.2013.06.022

Bae JS; Yuki N; Kuwabara S; Kim JK; Vucic S; Lin CS; Kiernan MC, 2014, 'Guillain-Barré syndrome in Asia', Journal of Neurology Neurosurgery and Psychiatry, 85, pp. 905 - 911, http://dx.doi.org/10.1136/jnnp-2013-306212

Geevasinga N; Menon P; Kiernan MC; Vucic S, 2014, 'Motor cortical function and the precision grip', Physiological Reports, 2, http://dx.doi.org/10.14814/phy2.12120

Kiernan MC, 2014, 'Remembrance of things future', Journal of Neurology Neurosurgery and Psychiatry, 85, pp. 1, http://dx.doi.org/10.1136/jnnp-2013-307129

Huynh W; Kiernan MC, 2014, 'Reply: Botulinum toxin injection for post-stroke spasticity', Muscle and Nerve, 49, pp. 932 - 933, http://dx.doi.org/10.1002/mus.24221

Leslie FVC; Hsieh S; Caga J; Mioshi E; Hornberger M; Kiernan MC; Hodges JR; Burrell JR, 2014, '13.', Journal of Clinical Neuroscience, 21, pp. 2037 - 2037, http://dx.doi.org/10.1016/j.jocn.2014.06.027

Devenney E; Hoon C; Kiernan M; Hodges J, 2014, '14.', Journal of Clinical Neuroscience, 21, pp. 2037 - 2037, http://dx.doi.org/10.1016/j.jocn.2014.06.028

Sung J-Y; Lin Y-C; Lin S-Y; Kiernan MC; Lin CS-Y, 2014, '14. Sensory axonal dysfunction in asymptomatic diabetic patients', Clinical Neurophysiology, 125, pp. e5 - e6, http://dx.doi.org/10.1016/j.clinph.2013.10.036

Menon P; Geevasingha N; Yiannikas C; Kiernan M; Vucic S, 2014, '15.', Journal of Clinical Neuroscience, 21, pp. 2037 - 2038, http://dx.doi.org/10.1016/j.jocn.2014.06.029

Geevasinga N; Menon P; Nicholson G; Ng K; Kiernan M; Vucic S, 2014, '16.', Journal of Clinical Neuroscience, 21, pp. 2038 - 2038, http://dx.doi.org/10.1016/j.jocn.2014.06.030

Devine M; Kiernan M; Pannek K; Rose S; McCombe P; Henderson R, 2014, '28.', Journal of Clinical Neuroscience, 21, pp. 2042 - 2042, http://dx.doi.org/10.1016/j.jocn.2014.06.042

Geevasinga N; Menon P; Kiernan MC; Vucic S, 2014, '3. Diagnostic utility of threshold tracking TMS in ALS: Comparative study to Awaji criteria', Clinical Neurophysiology, 125, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2013.10.025

Ahmed R; Irish M; Bartley L; Samaras K; Piguet O; Hodges J; Kiernan M, 2014, '30.', Journal of Clinical Neuroscience, 21, pp. 2042 - 2043, http://dx.doi.org/10.1016/j.jocn.2014.06.044

Murray JE; Pickering HR; Lin CS-Y; Goldstein D; Friedlander ML; Kiernan MC; Krishnan AV, 2014, '6. Functional impact of neuropathy in patients receiving oxaliplatin chemotherapy', Clinical Neurophysiology, 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.028

Garg N; Barnett MH; Yuki N; Kiernan MC, 2014, '60.', Journal of Clinical Neuroscience, 21, pp. 2052 - 2052, http://dx.doi.org/10.1016/j.jocn.2014.06.074

Geevasinga N; Menon P; Sue CM; Kumar KR; Ng K; Kiernan M; Vucic S, 2014, '63.', Journal of Clinical Neuroscience, 21, pp. 2052 - 2053, http://dx.doi.org/10.1016/j.jocn.2014.06.077

Wang C; Paling D; Chen L; Hatton S; Lagopoulos J; Aw S; Kiernan M; Barnett M, 2014, '66.', Journal of Clinical Neuroscience, 21, pp. 2053 - 2054, http://dx.doi.org/10.1016/j.jocn.2014.06.080

Pickering H; Lin CS-Y; Murray J; Kiernan MC; Krishnan AV, 2014, '7. Effects of fampridine PR on axonal function in multiple sclerosis', Clinical Neurophysiology, 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.029

Huynh W; Vucic S; Krishnan AV; Lin CS-Y; Kiernan MC, 2014, '8. Evolution and recovery of motor function post-stroke', Clinical Neurophysiology, 125, pp. e3 - e4, http://dx.doi.org/10.1016/j.clinph.2013.10.030

Rowin EJ; Maron BJ; Kiernan MS; Casey SA; Feldman DS; Hryniewicz KM; Chan RH; Harris KM; Udelson JE; DeNofrio D; Roberts WC; Maron MS, 2014, 'Advanced Heart Failure With Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy Under-Recognized Subset of Candidates for Heart Transplant', CIRCULATION-HEART FAILURE, 7, pp. 967 - U148, http://dx.doi.org/10.1161/CIRCHEARTFAILURE.114.001435

Burrell JR; Hornberger M; Vucic S; Kiernan MC; Hodges JR, 2014, 'Apraxia and motor dysfunction in corticobasal syndrome', PloS One, 9, pp. e92944 - e92944, http://dx.doi.org/10.1371/journal.pone.0092944

Meyer TE; Kiernan MS; McManus DD; Shih J, 2014, 'Decision-making under uncertainty in advanced heart failure.', Curr Heart Fail Rep, 11, pp. 188 - 196, http://dx.doi.org/10.1007/s11897-014-0195-7

Jumean MF; Kiernan MS, 2014, 'Determinants of survival following hospitalization for acute heart failure.', Curr Heart Fail Rep, 11, pp. 201 - 211, http://dx.doi.org/10.1007/s11897-014-0190-z

Li J; Geisbush TR; Rosen GD; Lachey J; Mulivor A; Rutkove SB, 2014, 'ELECTRICAL IMPEDANCE MYOGRAPHY FOR THE IN VIVO AND EX VIVO ASSESSMENT OF MUSCULAR DYSTROPHY ( mdx) MOUSE MUSCLE', MUSCLE & NERVE, 49, pp. 829 - 835, http://dx.doi.org/10.1002/mus.24086

Devenney E; Hornberger M; Irish M; Mioshi E; Burrell J; Tan R; Kiernan MC; Hodges JR, 2014, 'Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile', JAMA neurology, 71, pp. 331 - 339, http://dx.doi.org/10.1001/jamaneurol.2013.6002

Geevasinga N; Menon P; Yiannikas C; Kiernan M; Vucic S, 2014, 'O54: Diagnostic utility of cortical hyperexcitability in amyotrophic lateral sclerosis', Clinical Neurophysiology, 125, pp. S44 - S44, http://dx.doi.org/10.1016/s1388-2457(14)50157-5

Leslie FVC; Hsieh S; Caga J; Savage SA; Mioshi E; Hornberger M; Kiernan MC; Hodges JR; Burrell JR, 2014, 'Semantic deficits in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, pp. 1 - 8, http://dx.doi.org/10.3109/21678421.2014.987301

Huynh W; Krishnan AV; Vucic S; Lin CSY; Kiernan MC, 2013, 'Motor cortex excitability in acute cerebellar infarct', Cerebellum, 12, pp. 826 - 834, http://dx.doi.org/10.1007/s12311-013-0493-8

Simon NG; vucic S; Joffe R; Kiernan MC, 2013, 'Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase.', Journal of Neurology, 261, pp. 238 - 239, http://dx.doi.org/10.1007/s00415-013-7197-3

Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, http://dx.doi.org/10.1002/caac.21204

Simon NG; Reddel SW; Kiernan MC; Layzer R, 2013, 'Muscle-specific kinase antibodies: A novel cause of peripheral nerve hyperexcitability?', Muscle and Nerve, 48, pp. 819 - 823, http://dx.doi.org/10.1002/mus.23907

Arnold R; Pussell BA; Pianta TJ; Lin CSY; Kiernan MC; Krishnan AV, 2013, 'Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients', American Journal of Transplantation, 13, pp. 2426 - 2432, http://dx.doi.org/10.1111/ajt.12324

Simon N; Lee M; Howells J; Vucic S; Lin C; Kiernan M, 2013, 'Pathophysiological Changes in the H-Reflex Pathway in Amyotrophic Lateral Sclerosis (P07.075)', Neurology, 80, http://dx.doi.org/10.1212/wnl.80.7_supplement.p07.075

Simon N; Bae JS; Mioshi E; Lin C; Vucic S; Kiernan M, 2013, 'The Split Leg in Amyotrophic Lateral Sclerosis (P07.083)', Neurology, 80, http://dx.doi.org/10.1212/wnl.80.7_supplement.p07.083

Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, 63, pp. 419 - 437, http://dx.doi.org/10.3322/caac.21204

Williams KL; Fifita JA; Vucic S; Durnall JC; Kiernan MC; Blair IP; Nicholson GA, 2013, 'Pathophysiological insights into ALS with C9ORF72 expansions', Journal of Neurology Neurosurgery and Psychiatry, 84, pp. 931 - 935, http://dx.doi.org/10.1136/jnnp-2012-304529

Kiernan MC; Kaji R, 2013, 'Physiology and pathophysiology of myelinated nerve fibers', , 115, pp. 43 - 53, http://dx.doi.org/10.1016/B978-0-444-52902-2.00004-7

Vucic S; Kiernan MC, 2013, 'Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology', , 116, pp. 561 - 575, http://dx.doi.org/10.1016/B978-0-444-53497-2.00045-0

Vucic S; Nicholson G; Chio A; Kiernan MC, 2013, 'Apparent anticipation in SOD1 familial amyotrophic lateral sclerosis', Amyotroph Lateral Scler Frontotemporal Degener, 14, pp. 452 - 456, http://dx.doi.org/10.3109/21678421.2013.764569

Arnold R; Kwai NCG; Lin CS-Y; Poynten AM; Kiernan MC; Krishnan AV, 2013, 'Axonal dysfunction prior to neuropathy onset in type 1 diabetes', Diabetes - Metabolism Research and Reviews, 29, pp. 53 - 59, http://dx.doi.org/10.1002/dmrr.2360

Sahebally SM; Burke JP; Chang KH; Kiernan MG; O'Connell PR; Coffey JC, 2013, 'Circulating fibrocytes and Crohn's disease', BRITISH JOURNAL OF SURGERY, 100, pp. 1549 - 1556, http://dx.doi.org/10.1002/bjs.9302

Turner M; Hardiman O; Benatar ; Brooks BR; Chio A; De carvalho M; Ince PG; Lin CS-Y; Miller RG; Mitsumoto H; Nicholson G; Ravits J; Shaw P; Swash M; Talbot K; Traynor BJ; Van den berg LH; Veldink JH; Vucic S; Kiernan MC, 2013, 'Controversies and priorities in amyotrophic lateral sclerosis.', Lancet Neurology, 12, pp. 310 - 322, http://dx.doi.org/10.1016/S1474-4422(13)70036-X

Mioshi E; Lillo P; Yew B; Hsieh S; Savage S; Hodges JR; Kiernan MC; Hornberger M, 2013, 'Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes', Neurology, 80, pp. 1117 - 1123, http://dx.doi.org/10.1212/WNL.0b013e31828869da


Back to profile page